Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 83 days for 2021).
- 2025not filed
- 202410/10/2024
- 202329/03/2024
- 202106/10/2022
- 202015/07/2021
- 201911/09/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
National Health Fund (NFZ) contracts
Centralna Jargan - Szklorz has been an NFZ healthcare provider since 2008. In 2026 it is performing 5 contracts with a total value of USD 1.22k. All its contracts were worth USD 2.82k in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Pilot programmes | śląskie | 2 | USD 1.22k |
| Provision of medical devices | śląskie | 1 | USD 0.00 |
| Other services provided in pharmacies | śląskie | 2 | USD 0.00 |
Trademarks
Centralna Jargan - Szklorz currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2000.
| Mark | Protected until | |
|---|---|---|
| CENTRALNA | – |
Authorized Representatives
Manner of representation
Leszek Jargan and Andrzej Szklorz acting independently.
Ownership
| Owner |
|---|
Indra Sp. z o.o. |
Jolanta Izabela Jargan |
Leszek Piotr Jarganage 64 |
Agata Joanna Jargan Barańska |
Andrzej Roman Szklorzage 64 |
Katarzyna Danuta Szklorz |
Marta Patrycja Szklorz Papierniak |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1999-12-31.
17 2490 0005 0000 4530 7225 3815- 24 2490 0005 0000 4600 2388 8669
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,490$4,490 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,977$4,977 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,389$4,389 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Dolnośląska Grupa AptecznaS.A. | $30,168,188.68 | dgasa.pl | ||
| Management CompanyS.A. | $18,905,980.22 | managementcompany.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Herbarium Świętego Franciszkasp. z o.o. | $1,397,577.12 | herbarium.katowice.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-WarszawaS.A. | – | farmacol.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2017-08-11 | PKD change (Removed: 330 codes) | |
| 2010-03-10 | Switch to PKD 2007 (148 PKD 2004 codes → 336 PKD 2007 codes) | |
| 2006-06-07 | Entered in the register |
FAQ
Last updated: 2026-03-22